Contact the Fingenious® team

Whether you are interested in biospecimen, data or want to find study participants for your research, the Fingenious® team will help you. We work together with all Finnish public biobanks and their background organizations in the biobank network.

Contact us

We're ready to support you in your biomedical research efforts. Contact us now and we'll be in touch with you at the earliest opportunity.

Area of interest

Why Fingenious®?

Fingenious® Service helps academic and industry researchers all over the world in their biomedical research efforts, offering a single and easy point of access to Finnish public biobanks and the unique genetic heritage of Finns.

Finnish Biobank Cooperative – FINBB and its Fingenious® Service were established as part of the implementation of Finnish National Health Sector Growth Strategy, a joint program by three ministries.

Fingenious® Service allows researchers to perform quick biospecimen and data queries, and reach all the public biobanks in Finland with a centralized feasibility and access request, and one contract.

Subscribe to Fingenious newsletter

Get the latest scientific news and use cases in biomedical research.

Subscribe Now

News & Updates

Ecosystem

New from Oriola RWE Team: The clinical and economic burden of pneumonia and pneumococcal disease in Finland

Discover Oriola RWE team’s latest scientific project on disease burden and healthcare resource use of pneumonia in Finland. This nationwide project is based on unique real-world data from Finnish health registries. The Nordic countries provide ideal conditions for registry studies, thanks to harmonised laws, electronic data collection, and nationwide cohort creation.

Read more

Ecosystem

Combining data from different registries for research purposes in Finland - The lymphoma study combined data from six data controllers

Finland offers a unique and advantageous environment for conducting real-world evidence (RWE) studies. Data retrieved from the Finnish health and social care registries may be more representative compared to other countries. Therefore, Finland is a strong option when weighing in which country the research would be carried out in. This article by Medaffcon presents a multiregistry study combining health and social data.

Read more

Ecosystem

Post-licensure vaccine study expertise in Finland: case FVR

Fingenious® Ecosystem Partner, FVR – Finnish Vaccine Research Ltd., a special-assignment company of the Finnish state, conducts commercial vaccine studies in phases 1-4 with decades of experience and internationally recognized, high-quality scientific expertise. In addition to clinical vaccine trials, FVR has extensive experience in conducting phase 4 observational vaccine studies (RWE) and pragmatic clinical trials for evaluating vaccine effectiveness, safety, and disease burden. Explore FVR examples of post-licensure studies.

Read more
See all news